Pharmaceutical - UK

Filter

Current filters:

UK

Popular Filters

1 to 25 of 293 results

NICE backs Pradaxa for treating and preventing potentially fatal blood clots

NICE backs Pradaxa for treating and preventing potentially fatal blood clots

17-12-2014

In final guidance published today, UK health cost watchdog the National Institute for Health and Care…

Boehringer IngelheimCardio-vascularPharmaceuticalPradaxaPricingRegulationUK

UK’s NICE recommends Pfizer’s Inlyta for kidney cancer

UK’s NICE recommends Pfizer’s Inlyta for kidney cancer

16-12-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) has issued new…

InlytaOncologyPfizerPharmaceuticalPricingRegulationUK

UK NICE partially backs Bayer’s Xofigo in preliminary assessment

UK NICE partially backs Bayer’s Xofigo in preliminary assessment

15-12-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) have recommended…

BayerOncologyPharmaceuticalPricingRegulationUKXofigo

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

12-12-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalPricingRegulationRemicadeSimponi InjectionUK

Twin Swedish and Welsh life sciences hubs plan to share knowledge

Twin Swedish and Welsh life sciences hubs plan to share knowledge

12-12-2014

A Swedish cluster for life sciences, Medicon Village, visited the new Life Sciences Hub Wales center…

Medicon VillagePharmaceuticalResearchSwedenUK

Alzheimer's Research UK launches $31 million global clinical trials fund

Alzheimer's Research UK launches $31 million global clinical trials fund

12-12-2014

Alzheimer’s Research UK, the country’s leading dementia research charity, has launched a global clinical…

DementiaNeurologicalPharmaceuticalResearchUK

UK industry makes third quarter PPRS payment, Department of Health sets 2015 percentage at 10.36%

UK industry makes third quarter PPRS payment, Department of Health sets 2015 percentage at 10.36%

11-12-2014

The UK pharma industry has made its third quarter payment to underwrite the growth of the medicines bill…

ABPIDepartment of HealthPharmaceuticalRegulationUK

Recently-announced timeline of UK Patent Box changes helps address uncertainty, says patent attorney

04-12-2014

Following UK Chancellor of the Exchequer George Osborne’s confirmation of an overhaul of the Patent…

FinancialPatentsPharmaceuticalResearchUK

ABPI welcomes Chancellor’s decision to increase rate of R&D tax credits

04-12-2014

In his Autumn Statement yesterday, UK Chancellor of the Exchequer, George Osborne said he wants to help…

FinancialPharmaceuticalResearchUK

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

02-12-2014

The UK prime minister David Cameron is to announce a £15 million ($24 million) commitment to a new fund…

NeurologicalPharmaceuticalPoliticsResearchUK

FDA accepts NDA filing from AstraZeneca for Iressa

FDA accepts NDA filing from AstraZeneca for Iressa

02-12-2014

The US Food and Drug Administration has accepted for filing the New Drug Application from Iressa (gefitinib)…

AstraZenecaIressaOncologyPharmaceuticalRegulationUK

NICE reverses October decision and approves Roche's Gazyvaro

NICE reverses October decision and approves Roche's Gazyvaro

02-12-2014

The UK’s National Institute for Health and Care Excellence (NICE) has reversed its decision on Gazyvaro…

GazyvaroOncologyPharmaceuticalRegulationRocheUK

AstraZeneca signs drug discovery collaboration with Cancer Research UK

AstraZeneca signs drug discovery collaboration with Cancer Research UK

28-11-2014

UK pharma major AstraZeneca and charity Cancer Research UK have signed a memorandum of understanding…

AstraZenecaOncologyPharmaceuticalResearchUK

UK uses fewer branded medicines per person than comparable countries and is still using older therapies

UK uses fewer branded medicines per person than comparable countries and is still using older therapies

27-11-2014

The Association of the British Pharmaceutical Industry has published new research showing that UK use…

ABPIMarkets & MarketingPharmaceuticalRegulationUK

The Global Crisis of Depression conference: high co-morbidity, high costs, few answers

The Global Crisis of Depression conference: high co-morbidity, high costs, few answers

27-11-2014

John Andrews, consultant editor of The Economist, opened the Global Crisis of Depression conference by…

InterviewsLundbeckNeurologicalPharmaceuticalResearchSocial IssuesUK

MHRA showcases benefit of its industry collaboration with AstraZeneca's Macclesfield plant

MHRA showcases benefit of its industry collaboration with AstraZeneca's Macclesfield plant

27-11-2014

The UK's Medicines and Healthcare products Regulatory Agency has published a case study outlining the…

AstraZenecaOncologyPharmaceuticalProductionUK

Eisai opens £8 million packaging facility in UK

Eisai opens £8 million packaging facility in UK

26-11-2014

Japanese drug major Eisai has opened a new facility at its EMEA Knowledge Center in Hatfield, UK, to…

EisailenvatinibPharmaceuticalProductionUK

NICE updated guidance backs Novartis’ Glivec for GIST

26-11-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) has issued final…

GlivecNovartisOncologyPharmaceuticalPricingRegulationUK

UK's NICE recommends Selincro to help reduce alcohol dependence

UK's NICE recommends Selincro to help reduce alcohol dependence

26-11-2014

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Selincro (nalmefene)…

LundbeckNeurologicalPharmaceuticalRegulationSelincroUK

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

25-11-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaDuaklir GenuairPharmaceuticalRegulationRespiratory and PulmonaryUK

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

24-11-2014

Pharma, biotech and health care companies convened in London last week to update investors at the Jefferies…

FinancialHealth Medical PharmaPharmaceuticalRocheUK

Highlights from the Jefferies 2014 Global Healthcare Conference

Highlights from the Jefferies 2014 Global Healthcare Conference

21-11-2014

Pharma, biotech and health care companies convened in London this week to update investors at the Jefferies…

ALK AbelloClinigen GroupCubistFinancialGW PharmaceuticalsPeter GeorgePharmaceuticalUK

Oncology specialists say UK's capacity crisis is impacting patient care

Oncology specialists say UK's capacity crisis is impacting patient care

21-11-2014

A survey carried out by Swiss drug major Roche has shown that frontline staff believe patient care is…

Markets & MarketingOncologyPharmaceuticalResearchRocheUK

1 to 25 of 293 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top